Interferon alfa-n1

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51342700
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51342708

This classification denotes an interferon, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47BPR3V3MP. European Medicines Agency schedules Interferon alfa-n1 in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20625. As of Q4 2014, INTERFERON ALFA-N1 remains the US FDA Preferred Term for this commodity. Interferon alfa-n1 bears US NLM identifiers UMLS ID C0699817 and NCI Concept Code C2220. SMILES: NONE.

Same parent

Under 51342700 · 14

51342701 Atazanavir Commodity 51342702 Enfuvirtide Commodity 51342703 Telaprevir Commodity 51342704 Boceprevir Commodity 51342705 Interferon alfa-2a Commodity 51342706 Interferon alfa-2b Commodity 51342707 Interferon alfacon-1 Commodity 51342708 Interferon alfa-n1 You are here 51342709 Interferon beta-1a Commodity 51342710 Interferon beta-1b Commodity 51342711 Interferon gamma-1b Commodity 51342712 Peginterferon alfa-2b Commodity 51342713 Atazanavir sulfate Commodity 51342714 Peginterferon alfa-2a Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51340000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.